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Abstract Prolonged human life duration is consequently associated with a higher incidence of chronic 
diseases. Aging is a very complex process in which genetic, environmental and cellular pathways are 
involved. Along with aging, longevity has been linked with Sirtuins. Sirtuin enzymes are a family of 
highly conserved protein deacetylases that have been linked with calorie restriction and aging by 
modulating energy metabolism, genomic stability and stress resistance. Aim of this brief review is to 
describe Sirtuins’ influence on the conditions that worsen the physiological aging. We will also report 
the beneficial effects of the polyphenol resveratrol on these molecules and the possible therapeutical 
perspectives. 
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1. Introduction 
 
The growing interest of scientists and researchers about aging may be also explained if we consider 
that the prolonged human life duration is consequently associated with increasing costs of public 
health due to the higher incidence of chronic diseases like diabetes, kidney failure, hypertension, 
neurodegenerative diseases, osteoporosis and cancer. From this point of view the future health 
challenge is to provide people with a better aging without excessive health costs. 
 
At the date, if you type on PubMed screen the query “aging”, more than 330000 results will be shown. 
Modern societies, expecially the western ones, are aging due to the prolonged life span, the reduced 
birth rates and the technological and scientific advances. 
 
Different hypotheses have been postulated to explain aging and its underlying mechanisms. We 
actually know that it is a very complex process in which genetic, environmental and cellular pathways 
are involved. Among these, oxidative stress was widely investigated for its tight implications in 
vascular aging that plays a key role in this process. In fact, cardiovascular and cerebrovascular events 
are significantly more frequent in aging adults [1]. 
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Along with aging, longevity was largely focused. Caloric restriction (CR) is a nutritional technique used 
in different models as a healthy method to prolong lifespan [2] through a reduction of calorie intake by 
30-40% but avoiding malnutrition. This method’s effects could be mediated by Sirtuins. 
 
2. Sirtuins 
 
Sirtuin enzymes are a family of highly conserved protein deacetylases that depend on nicotinamide 
adenine dinucleotide (NAD+) for their activity. Sirtuins catalyze the removal of acetyl groups from 
lysine residues. They may promote different post translational modifications in a wide range of 
proteins so they are actually defined as deacylases [3].  
 
Seven Sirtuins have been actually identified in mammals, listed from 1 to 7. Each of them exhibits a 
catalytic domain present in all Sirtuins whilst different N- and C- ends give to these proteins their 
characteristical biological properties.  
 
They have distinct subcellular localizations: SIRT1, 6 and 7 are nuclear; SIRT2 is cytosolic whilst 
SIRT3, 4 and 5 are primarily located in mitochondria [4]. Among these proteins, only SIRT4 has no a 
known deacetylation substrate [5]. 
 
Sirtuins were originally investigated in yeast and they have been linked with calorie restriction and 
aging by modulating energy metabolism, genomic stability and stress resistance [6]. SIRT4 and 
SIRT6 also exhibit ADP-ribosyl-transferase activity [7]. 
 
For each of the formerly mentioned chronic diseases, a direct or indirect role of one or more Sirtuins 
has been demonstrated.  
 
Aim of this brief review is to describe Sirtuins’ influence on the conditions that worsen the 
physiological aging. We will also report the beneficial effects of the polyphenol resveratrol on these 
molecules and the possible therapeutical perspectives. 
 
3. Sirtuins, Glucose Metabolism and Kidney Disease 
 
In animal models, SIRT1 influences glucose-dependent insulin production in pancreatic beta-cells [8, 
9] whose proliferation is negatively regulated by the same Sirtuin. Mitochondrial SIRT4 inhibits insulin 
secretion in response to aminoacids. In insulinoma cells an overexpression of SIRT4 has been 
demonstrated, thus leading to a decreased insulin synthesis as a reaction to blood glucose 
concentration [3]. 
 
In the liver SIRT1 promotes gluconeogenesis and blunts glycolysis via deacetylation of PGC-1 
(PPAR- coactivator-1) [10]. 
 
The same deacetylase enhances insulin sensitivity by modulating insulin signalling [11], inhibits fat 
storage and stimulates fatty acids release in white adipose tissue [12]. 
 
Transgenic overexpression of SIRT1 not only prevents diabetes in animal models, but also dulls 
diabetes that occurs during normal aging [13, 14]. Similarly, chemical activation of SIRT1 has 
antidiabetic and other beneficial effects. SRT1720 is one of potential SIRT1 activators being 
examined in clinical trials. 
 
Recently also SIRT6 has been proved to be involved in metabolic control: in fact, its absence is likely 
related to an enhancement of insulin signalling with consequent hypoglycemia [15]. With its histone 
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deacetylase activity, Sirt6 regulates the glucose levels through the blockade of different glycolytic 
genes [16]. 
 
This is more interesting if we consider the high incidence of diabetes and its complications among 
which diabetic nephropathy plays a leading role as a major determinant of morbidity and mortality 
[17]. A protective effect of Sirtuins in kidney is widely demonstrated by different mechanisms: they 
blunt hypoxia, reduce fibrosis, inhibit apoptosis and inflammation, reduce autophagy and modulate 
blood pressure [18]. For what concerns the last item, SIRT1 acts through the regulation of vascular 
tone and the handling of renal sodium in the collecting duct [19, 20].  
 
Moreover, SIRT3 attenuates lipotoxicity and ROS-related inflammation in proximal tubular cells, thus 
underlining the protective role of these molecules against oxidative stress in its multiple tissue 
expression [21]. SIRT3 is also able to regulate fatty acids metabolism and promotes lipid catabolism 
by deacetylating various mitochondrial proteins [22]. 
 
4. Sirtuins, DNA Stability, Oxidative Stress and Cancer 
 
Aging is accelerated by DNA damage. Sirtuins rescue this damage. SIRT1, one of the most 
investigated in this field, can deacetylate several factors involved in DNA reparation and genomic 
stability [23]. 
 
Also SIRT6 plays a role in genome stabilization, gene expression and DNA repair. Its deacetylation 
activity reduces chromosomal instability which is a fundamental feature of human cancer cells [24]. 
On the other hand, SIRT6 allows repair factors to reach chromatin thus minimizing DNA damage [25]. 
SIRT6 chromosomal locus is frequently broken in human acute myeloid leukemia [26]. In addition, the 
same deacetylase influences transcriptional activity through the inhibition of NF-B target genes, 
especially those associated with aging [27]. It is known that NF-B is a central factor for aging, 
inflammation, immunity and cell proliferation; for many authors this is the link between all these 
conditions and aging. 
 
Oxidative stress, along with other factors, is involved in chronic obstructive pulmonary disease 
(COPD) which is associated, on its turn, with the premature lung senescence. SIRT6 is significantly 
decreased in lung of patients with severe COPD [28]. In this clinical condition, NF-B regulates the 
expression of genes for proinflammatory molecules [29]. 
 
We know that ROS may damage nucleic acids, thus eliciting the onset of cancer (whose incidence 
grows in elder). In animal models the lack of SIRT3 is associated with greater genomic instability and 
increased sensitivity to oncogenic transformation if compared with controls [30]. 
 
The protective role of SIRT3 is also suggested by the observation that several human neoplastic 
tissues exhibit reduced SIRT3 levels when compared with healthy tissues [30]. Overexpression of the 
same Sirtuin suppresses cancer proliferation by inhibiting the activity of Hypoxia Inducible Factor-1- 
(HIF-1-) [31, 32]. It is interesting to underline that this factor is activated and stabilized by ROS thus 
strengthening the role of oxidative stress. 
 
From the study of different human tumours, SIRT3 emerges as a powerful, cell-specific and very 
complex tumor suppressor [33]. 
 
As a further demonstration of its antioxidant activity, in mice SIRT3 delayed the age-related hearing 
loss by enhancing mitochondrial antioxidant defenses [34]. 
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As mentioned above, SIRT1 is the most investigated about its possible relationship with cancer, but 
only SIRT7 has been seriously linked with different cancer types. In fact, it has been found to be 
overexpressed in tumours originating from thyroid, breast, bladder, liver and colon, thus leading to the 
working hypothesis that it could be a potential oncogene [35]. 
 
5. Sirtuins and Neurodegenerative Diseases 
 
In light of the former considerations, it’s easy to understand that Sirtuin enzymes are potential 
therapeutic targets in several human diseases including cancer, diabetes, inflammatory disorders and 
neurodegenerative diseases.  
 
In fact it is reasonable to hypothesize that a selective modulation of a single Sirtuin could beneficially 
affect different clinical conditions. For example, SIRT6 is an attractive target for the prevention and 
treatment of inflammatory, cardiovascular and pulmonary diseases [5]. 
 
Modulation of Sirtuin activity has been shown to impact the course of several aggregate-forming 
neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, Huntington's 
disease, amyotrophic lateral sclerosis and spinal and bulbar muscular atrophy.  
 
Lewy bodies are frequently found in many of these disorders and consist of protein inclusions whose 
major constituent is α-Synuclein (α-Syn), a presynaptic neuronal protein that besides the brain is 
widely expressed in other tissues. This protein has been pointed out to be a target of cellular protein 
quality control whose activity is impaired by aging thus causing neurodegeneration. On the other 
hand, the same protein could influence the protein quality control system. Sirtuins can influence the 
progression of neurodegenerative disorders by modulating transcription factor activity and directly 
deacetylating proteotoxic species, expecially the ones involved in autophagy degradation pathway 
[36]. 
 
6. Sirtuins and Resveratrol 
 
Further research is needed but on our opinion Sirtuins could become an interesting and powerful 
target to treat many human diseases. 
 
At this regard we would like to underline the potential role of resveratrol, a natural Phytoalexin 
compound, which was extensively studied for its antioxidant and radicals’ scavenging properties. 
More recently, this polyphenol has been shown to interact also with Sirtuins and from these complex 
(direct and indirect) interactions a putative therapeutical role for many of the above mentioned 
diseases could arise.  
 
It is a common observation that a healthy diets associated with a delayed onset of stroke and 
neurological diseases. Regular consumption of fruit, vegetables and fish reduces the risk of cognitive 
decline in the elderly population. Old people who regularly drink red wine exhibit a reduced (up to 
50%) risk of developing dementia [37]. These neuroprotective effects of resveratrol could be partially 
mediated by SIRT1 activation and scavenging activity. Moreover Resveratrol could influence amyloid 
generation and clearance [38]. However, Resveratrol’s poor absorption and availability (less than 1%) 
in human it is well known, besides its fast metabolism [39]. Biotechnology is actually working to 
develop different formulations (e.g. nanocapsules) that could provide a higher dose of resveratrol 
without eliciting its side effects (frequently nausea and diarrhea) [40]; daily doses less than 1g are 
generally considered safe. Resveratrol is able in lowering blood glucose levels via an increase in 
GLP-1 production in mice. More recently, in type 2 diabetic subjects supplemented with a daily 
resveratrol dose at 10 mg, Brasnyo and coworkers [41] observed an improvement of insulin 
sensitivity, a reduction in oxidative stress and in postprandial glucose spike. In subjects with metabolic 
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syndrome treated with resveratrol for six months improved flow-mediated dilation was observed and 
this beneficial effect disappeared when resveratrol treatment was stopped [42]. In diabetics 
resveratrol supplement for three months was associated with a better fasting blood glucose, blood 
pressure, triglycerides and LDL cholesterol levels if compared with subjects with a standard 
antidiabetic treatment [43]. 
 
For a better understanding of resveratrol effects in humans, we have to say that trials are not really 
comparable for sample size, aims, methods and resveratrol dose but we can say that resveratrol is a 
powerful SIRT1 activator, may be directly. This activation, on its turn, induces deacetylation and 
suppresses the activity of the Foxo1 transcription factor which is involved in insulin signaling due to its 
inhibitory role in glucose uptake and utilization in skeletal muscle [44]. This is interesting if we 
consider that aging and diabetic subjects usually exhibit a significant reduction in skeletal muscle 
mass and strength thus worsening the sedentary way of life that is typically observed in these people 
and that contributes to make these subjects more prone to obesity and its complications. 
 
The same SIRT1/Foxo1 axis has been recently postulated to be involved in cardiac aging. In fact 
heart performance decreases with age and Foxo1-related apoptotic signalling increases. A long term 
treatment with resveratrol improves cardiac function in senescent mice also by reducing age-induced 
deposition of collagen fibers [45]. 
 
Besides the well-known antioxidant effects, resveratrol could be a promising natural approach to 
many of the age-related disorders.  
 
In our previous papers we suggested that a moderate and regular wine consumption, in the wide 
frame of Mediterranean diet, could be useful to prevent and treat cardiovascular, metabolic and renal 
disorders [46-49]. 
 
Recently, Russo and coworkers [51] proposed Sirtuins-resveratrol axis as a model to deeply 
investigate the beneficial effects of the Mediterranean diet: in fact this food regimen positively 
influences microbioma composition and stem cell function by means of the activity of many useful 
components, resveratrol included. 
 
Many efforts are needed to better understand these molecular mechanisms but it is reasonable to 
hypothesize that a similar advice could be suggested to delay the onset of aging and its 
complications. 
 
7. Conclusion 
 
Many efforts are needed to better understand these molecular mechanisms but it is reasonable to 
hypothesize that a similar advice could be suggested to delay the onset of aging and its 
complications. From this point of view, dietary and lifestyle interventions could be useful instead of 
drugs thus significantly saving public resources.   
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